We found these obvious differences in gut microbiota and microbe-derived metabolites between different groups, indicating the beneficial effects of engineered bacteria in modulating the gut-brain axis, thereby enhancing insulin action to normal levels and targeting to prevent and counteract obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.